
International Journal of Nanomedicine, Год журнала: 2024, Номер Volume 19, С. 13113 - 13134
Опубликована: Дек. 1, 2024
Phosphodiesterase-4 is an enzyme that regulates immune responses and contributes to the development of psoriasis. Dipyridamole roflumilast function as phosphodiesterase-4 inhibitors, reducing pro-inflammatory cytokine expression. The aim was evaluate anti-psoriatic effect topical administration dipyridamole nanoemulgel combination on imiquimod-induced psoriasiform skin inflammation in rats.
Язык: Английский